NCT00137488View on ClinicalTrials.gov

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2007

Conditions
Glioma
Interventions
DEVICE

imaging and angiogenic profiles

Image tumor angiogenesis by DCE-MRI using 1.5- or 3-T MRI instruments (13,14,15) pre-and postoperatively (before biopsy or surgery).

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER

NCT00137488 - Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) | Biotech Hunter | Biotech Hunter